Document Detail

Novel targets for inflammatory bowel disease therapeutics.
MedLine Citation:
PMID:  23314806     Owner:  NLM     Status:  In-Data-Review    
In recent years, many new agents have been evaluated for the treatment of inflammatory bowel disease. In this paper, we critically review recently published literature about these novel therapies, which have been the result of extensive research identifying molecular targets. Of the various biologicals and small molecules that have recently been tested in clinical trials, several demonstrated clinical efficacy with a tolerable safety profile. We discuss a number of them with specific focus on vedolizumab, a monoclonal antibody directed against the alpha4beta7 integrin on lymphocytes, ustekinumab, a monoclonal antibody against the p40 subunit of interleukin-12 and interleukin-23, and tofacitinib, a small molecule targeting Janus-activated kinase. Most likely, these three agents will find their way to the market and offer significant therapeutic alternatives for the management of Crohn's disease and/or ulcerative colitis.
Mark Löwenberg; Geert D'Haens
Related Documents :
15876766 - Wolman disease: diagnosis by leucocyte acid lipase estimation.
10690726 - Cowden disease and lhermitte-duclos disease: characterization of a new phakomatosis.
2677046 - Massive osteolysis of the femur (gorham's disease): a case report and review of the lit...
18385566 - Pulsed and color doppler sonographic findings of penile mondor's disease.
23627546 - Severe vitamin d deficiency is associated with nontuberculous mycobacterial lung diseas...
20471476 - Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestatio...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current gastroenterology reports     Volume:  15     ISSN:  1534-312X     ISO Abbreviation:  Curr Gastroenterol Rep     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888896     Medline TA:  Curr Gastroenterol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  311     Citation Subset:  IM    
Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Treatment of hepatitis C: how will we use viral kinetics, response-guided therapy?
Next Document:  Is pulse oximetry an essential tool or just another distraction? The role of the pulse oximeter in m...